scholarly article | Q13442814 |
P356 | DOI | 10.1093/NAR/GKR208 |
P953 | full work available at URL | http://academic.oup.com/nar/article-pdf/39/15/6620/16774287/gkr208.pdf |
https://academic.oup.com/nar/article-pdf/39/15/6620/16774287/gkr208.pdf | ||
https://europepmc.org/articles/PMC3159436 | ||
https://europepmc.org/articles/PMC3159436?pdf=render | ||
P932 | PMC publication ID | 3159436 |
P698 | PubMed publication ID | 21531700 |
P5875 | ResearchGate publication ID | 51087957 |
P50 | author | Gabriele Zoppoli | Q56850332 |
Yves Pommier | Q28320644 | ||
Ilaria Dalla Rosa | Q40933116 | ||
William Reinhold | Q42631974 | ||
P2093 | author name string | Hongfang Liu | |
Céline Douarre | |||
P2860 | cites work | Mitochondrial DNA mutations in disease and aging. | Q55052993 |
Expression of the TAF4b gene is induced by MYC through a non-canonical, but not canonical, E-box which contributes to its specific response to MYC | Q82668986 | ||
DNA topoisomerases: structure, function, and mechanism | Q22065417 | ||
The layered structure of human mitochondrial DNA nucleoids | Q24302290 | ||
Human DNA2 is a mitochondrial nuclease/helicase for efficient processing of DNA replication and repair intermediates | Q24312975 | ||
AP4 encodes a c-MYC-inducible repressor of p21 | Q24316196 | ||
Role of SUV3 helicase in maintaining mitochondrial homeostasis in human cells | Q24320354 | ||
MTERF3 is a negative regulator of mammalian mtDNA transcription | Q24323198 | ||
A gene atlas of the mouse and human protein-encoding transcriptomes | Q24568043 | ||
Multiple pathways for sorting mitochondrial precursor proteins | Q24645926 | ||
A mitochondrial protein compendium elucidates complex I disease biology | Q24655079 | ||
Global mapping of c-Myc binding sites and target gene networks in human B cells | Q24675083 | ||
The Myc/Max/Mad network and the transcriptional control of cell behavior | Q28141143 | ||
DNA topoisomerases and their poisoning by anticancer and antibacterial drugs | Q28284744 | ||
Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set | Q28389579 | ||
The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry | Q28580062 | ||
Genome-wide mRNA and microRNA profiling of the NCI 60 cell-line screen and comparison of FdUMP[10] with fluorouracil, floxuridine, and topoisomerase 1 poisons | Q28741878 | ||
Exon array analyses across the NCI-60 reveal potential regulation of TOP1 by transcription pausing at guanosine quartets in the first intron | Q28749651 | ||
A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine | Q29547303 | ||
The NCI60 human tumour cell line anticancer drug screen | Q29614975 | ||
A gene expression database for the molecular pharmacology of cancer | Q29619242 | ||
Transcriptional paradigms in mammalian mitochondrial biogenesis and function | Q29619590 | ||
Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays | Q30449558 | ||
Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes | Q30834866 | ||
MTERF2 is a nucleoid component in mammalian mitochondria | Q30973919 | ||
Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel | Q31038779 | ||
Global identification of Myc target genes reveals its direct role in mitochondrial biogenesis and its E-box usage in vivo | Q33323393 | ||
Thirteen-exon-motif signature for vertebrate nuclear and mitochondrial type IB topoisomerases | Q33832261 | ||
Analysis of Food and Drug Administration-approved anticancer agents in the NCI60 panel of human tumor cell lines | Q33843555 | ||
mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities | Q33889761 | ||
Human mitochondrial topoisomerase I | Q33943662 | ||
Targeting mitochondria for cancer therapy | Q34115304 | ||
Identification of rare DNA variants in mitochondrial disorders with improved array-based sequencing | Q34474098 | ||
Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion | Q35107957 | ||
Mitochondrial DNA replication: what we know | Q35184640 | ||
The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression | Q35890670 | ||
Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network | Q35965143 | ||
Nuclear control of respiratory gene expression in mammalian cells | Q36331586 | ||
Mitochondrial topoisomerases and alternative splicing of the human TOP1mt gene | Q36680245 | ||
Mammalian mitochondrial nucleoids: organizing an independently minded genome. | Q36910046 | ||
Mitochondrial topoisomerase I sites in the regulatory D-loop region of mitochondrial DNA. | Q37001842 | ||
Adaptation of topoisomerase I paralogs to nuclear and mitochondrial DNA. | Q37406087 | ||
MYC-induced cancer cell energy metabolism and therapeutic opportunities | Q37438881 | ||
Functional organization of mammalian mitochondrial DNA in nucleoids: history, recent developments, and future challenges. | Q37655959 | ||
Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis | Q38324237 | ||
Identifying genes regulated in a Myc-dependent manner | Q38363958 | ||
Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. | Q38516613 | ||
A journey in the world of DNA rings and beyond | Q38571383 | ||
Karyotypic complexity of the NCI-60 drug-screening panel. | Q40604171 | ||
A large scale genetic analysis of c-Myc-regulated gene expression patterns | Q40677486 | ||
Identification of c-myc responsive genes using rat cDNA microarray. | Q40841505 | ||
Human prohibitin 1 maintains the organization and stability of the mitochondrial nucleoids | Q46766105 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 2.5 Generic | Q19113746 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 15 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | regulation of gene expression | Q411391 |
P1104 | number of pages | 13 | |
P304 | page(s) | 6620-6632 | |
P577 | publication date | 2011-04-29 | |
P1433 | published in | Nucleic Acids Research | Q135122 |
P1476 | title | Coordinated regulation of mitochondrial topoisomerase IB with mitochondrial nuclear encoded genes and MYC | |
P478 | volume | 39 |
Q36103111 | CellMiner: A Web-Based Suite of Genomic and Pharmacologic Tools to Explore Transcript and Drug Patterns in the NCI-60 Cell Line Set |
Q34388355 | Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction |
Q33566777 | KRAS-dependent suppression of MYC enhances the sensitivity of cancer cells to cytotoxic agents |
Q36056695 | Lack of mitochondrial topoisomerase I (TOP1mt) impairs liver regeneration |
Q37717928 | MYC and mitochondrial biogenesis |
Q34387659 | Mitochondrial Topoisomerase I is Critical for Mitochondrial Integrity and Cellular Energy Metabolism |
Q37327630 | Negative regulation of mitochondrial transcription by mitochondrial topoisomerase I. |
Q42946931 | Screening of JAK2 V617F and MPL W515 K/L negative essential thrombocythaemia patients for mutations in SESN2, DNAJC17, ST13, TOP1MT, and NTRK1. |
Q26826831 | Using CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60 |
Search more.